Efficacy and safety of maintenance therapy with pamiparib versus placebo for advanced gastric cancer responding to first-line platinum-based chemotherapy: Phase 2 study results […]Read More… from Efficacy and safety of maintenance therapy with pamiparib versus placebo for advanced gastric cancer responding to first-line platinum-based chemotherapy: Phase 2 study results
Accuracy and Prognostic Significance of Oncologists’ Estimates and Scenarios for Survival Time in Advanced Gastric Cancer […]Read More… from Accuracy and Prognostic Significance of Oncologists’ Estimates and Scenarios for Survival Time in Advanced Gastric Cancer
Health-related quality of life associated with regorafenib treatment in refractory advanced gastric adenocarcinoma. […]Read More… from Health-related quality of life associated with regorafenib treatment in refractory advanced gastric adenocarcinoma.
Cytogenetic and DNA analysis of two neuroectodermal tumors without a simple t(11;22). […]Read More… from Cytogenetic and DNA analysis of two neuroectodermal tumors without a simple t(11;22).
Dose-intensive cyclophosphamide with etoposide and vincristine for pediatric solid tumors: a phase I/II pilot study by the Australia and New Zealand Childhood Cancer Study Group […]Read More… from Dose-intensive cyclophosphamide with etoposide and vincristine for pediatric solid tumors: a phase I/II pilot study by the Australia and New Zealand Childhood Cancer Study Group
CD73 and PD-L1 as Potential Therapeutic Targets in Gallbladder Cancer […]Read More… from CD73 and PD-L1 as Potential Therapeutic Targets in Gallbladder Cancer
Interleukin-11 is the dominant IL-6 family cytokine during gastrointestinal tumorigenesis and can be targeted therapeutically […]Read More… from Interleukin-11 is the dominant IL-6 family cytokine during gastrointestinal tumorigenesis and can be targeted therapeutically
Enrichment of multiple immune checkpoints in cholangiocarcinoma cancer stem cells […]Read More… from Enrichment of multiple immune checkpoints in cholangiocarcinoma cancer stem cells
Mechanisms of Immune Cell Dysregulation in Pancreatic Ductal Adenocarcinoma […]Read More… from Mechanisms of Immune Cell Dysregulation in Pancreatic Ductal Adenocarcinoma
Other Cancers